Holdings of Victory Science & Technology Fund
Victory Portfolios III · 178 declared positions · as of Apr 30, 2026
Original filing · Net assets 1.4B $ · Ten largest lines: 45.1 % of the equity sleeve
Sector breakdown
- Technology 53.1 %
- Communication 12.4 %
- Consumer discretionary 4.0 %
- Health care 3.3 %
- Financials 1.7 %
- Industrials 0.2 %
- Unattributed 25.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 99.0 %
- KRW 0.5 %
- TWD 0.5 %
The quoted currency of each line, as declared.
Country breakdown
- US 95.4 %
- KY 1.2 %
- CA 1.0 %
- NL 0.8 %
- KR 0.5 %
- TW 0.5 %
- SG 0.3 %
- IL 0.3 %
- GB 0.0 %
- CH 0.0 %
- HK 0.0 %
- BE 0.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 157 | 1.3B $ | 95.37 % |
| 2 | KY | 1 | 15.9M $ | 1.17 % |
| 3 | CA | 4 | 13.9M $ | 1.03 % |
| 4 | NL | 3 | 11.1M $ | 0.82 % |
| 5 | KR | 1 | 6.8M $ | 0.50 % |
| 6 | TW | 1 | 6.4M $ | 0.47 % |
| 7 | SG | 1 | 4.4M $ | 0.33 % |
| 8 | IL | 2 | 3.7M $ | 0.27 % |
| 9 | GB | 2 | 163.3K $ | 0.01 % |
| 10 | CH | 2 | 95.9K $ | 0.01 % |
| 11 | HK | 2 | 78K $ | 0.01 % |
| 12 | BE | 1 | 75.1K $ | 0.01 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | Corning Inc | 7,211 | 1.2M $ | 0.08 % |
| 102 | Airbnb Inc | 8,146 | 1.1M $ | 0.08 % |
| 103 | CYBERARK SOFTWARE LTD | 24,033 | 1.1M $ | 0.08 % |
| 104 | MKS Inc | 3,614 | 1M $ | 0.07 % |
| 105 | CAMP4 THERAPEUTICS CORP | 226,602 | 944.9K $ | 0.07 % |
| 106 | HubSpot Inc | 4,156 | 921.6K $ | 0.07 % |
| 107 | Corpay Inc | 2,993 | 917.3K $ | 0.07 % |
| 108 | Gartner Inc | 5,809 | 862.6K $ | 0.06 % |
| 109 | Fortinet Inc | 8,371 | 705.8K $ | 0.05 % |
| 110 | Pinterest Inc | 32,788 | 644.6K $ | 0.05 % |
| 111 | Merck & Co Inc | 5,521 | 602.8K $ | 0.04 % |
| 112 | Johnson & Johnson | 2,528 | 581.1K $ | 0.04 % |
| 113 | UnitedHealth Group Inc | 1,477 | 547.2K $ | 0.04 % |
| 114 | Intuitive Surgical Inc | 763 | 349.2K $ | 0.02 % |
| 115 | AbbVie Inc | 1,414 | 298.8K $ | 0.02 % |
| 116 | Abbott Laboratories | 2,966 | 269.3K $ | 0.02 % |
| 117 | Danaher Corp | 1,450 | 259.5K $ | 0.02 % |
| 118 | Edwards Lifesciences Corp | 2,902 | 242.3K $ | 0.02 % |
| 119 | CVS Health Corp | 2,816 | 234.5K $ | 0.02 % |
| 120 | Boston Scientific Corp | 3,870 | 223K $ | 0.02 % |
| 121 | Elevance Health Inc | 530 | 199.5K $ | 0.01 % |
| 122 | Cencora Inc | 636 | 195.9K $ | 0.01 % |
| 123 | Thermo Fisher Scientific Inc | 374 | 179.1K $ | 0.01 % |
| 124 | Regeneron Pharmaceuticals, Inc. | 252 | 178.2K $ | 0.01 % |
| 125 | HCA Healthcare Inc | 396 | 172K $ | 0.01 % |
| 126 | Biogen Inc | 671 | 127K $ | 0.01 % |
| 127 | GSK PLC | 4,770 | 125K $ | 0.01 % |
| 128 | Agilent Technologies Inc | 1,063 | 122.8K $ | 0.01 % |
| 129 | Cardinal Health, Inc. | 634 | 122.3K $ | 0.01 % |
| 130 | United Therapeutics Corp | 200 | 114.3K $ | 0.01 % |
| 131 | Stryker Corp | 361 | 113.8K $ | 0.01 % |
| 132 | Medtronic PLC | 1,393 | 112.8K $ | 0.01 % |
| 133 | Dexcom Inc | 1,645 | 98K $ | 0.01 % |
| 134 | Kailera Therapeutics Inc | 3,360 | 84K $ | 0.01 % |
| 135 | STERIS PLC | 369 | 80K $ | 0.01 % |
| 136 | Ionis Pharmaceuticals Inc | 1,036 | 77.5K $ | 0.01 % |
| 137 | Incyte Corp | 807 | 76.9K $ | 0.01 % |
| 138 | UCB SA | 276 | 75.1K $ | 0.01 % |
| 139 | Alnylam Pharmaceuticals Inc | 242 | 74.9K $ | 0.01 % |
| 140 | Bristol-Myers Squibb Co | 1,179 | 71.4K $ | 0.01 % |
| 141 | Ascendis Pharma A/S | 298 | 68.4K $ | 0.00 % |
| 142 | Madrigal Pharmaceuticals Inc | 131 | 67.8K $ | 0.00 % |
| 143 | Elanco Animal Health Inc | 2,880 | 64.4K $ | 0.00 % |
| 144 | Encompass Health Corp | 636 | 63.6K $ | 0.00 % |
| 145 | HeartFlow Inc | 1,926 | 57.3K $ | 0.00 % |
| 146 | Galderma Group AG | 267 | 56K $ | 0.00 % |
| 147 | ICON PLC | 452 | 53.5K $ | 0.00 % |
| 148 | Cytokinetics Inc | 833 | 53.3K $ | 0.00 % |
| 149 | Arcus Biosciences Inc | 2,077 | 53K $ | 0.00 % |
| 150 | Bio-Techne Corp | 941 | 52.1K $ | 0.00 % |
| 151 | Pharvaris NV | 1,659 | 51.4K $ | 0.00 % |
| 152 | Avantor Inc | 6,234 | 50.5K $ | 0.00 % |
| 153 | Mirum Pharmaceuticals Inc | 507 | 49.3K $ | 0.00 % |
| 154 | Scholar Rock Holding Corp | 987 | 46K $ | 0.00 % |
| 155 | PTC Therapeutics Inc | 694 | 45.2K $ | 0.00 % |
| 156 | GenFleet Therapeutics Shanghai Inc | 7,550 | 42K $ | 0.00 % |
| 157 | Dianthus Therapeutics Inc | 465 | 40.8K $ | 0.00 % |
| 158 | Acadia Healthcare Co Inc | 1,566 | 40.6K $ | 0.00 % |
| 159 | Celldex Therapeutics Inc | 1,231 | 40.5K $ | 0.00 % |
| 160 | Alignment Healthcare Inc | 1,794 | 40.4K $ | 0.00 % |
| 161 | Adaptive Biotechnologies Corp | 2,867 | 40.4K $ | 0.00 % |
| 162 | Oculis Holding AG | 1,450 | 39.8K $ | 0.00 % |
| 163 | Inspire Medical Systems Inc | 701 | 39.4K $ | 0.00 % |
| 164 | QIAGEN NV | 1,120 | 38.7K $ | 0.00 % |
| 165 | AstraZeneca PLC | 204 | 38.2K $ | 0.00 % |
| 166 | Option Care Health Inc | 1,871 | 38K $ | 0.00 % |
| 167 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 4,318 | 36K $ | 0.00 % |
| 168 | Mineralys Therapeutics Inc | 1,348 | 35.9K $ | 0.00 % |
| 169 | Immunome Inc | 1,553 | 35.6K $ | 0.00 % |
| 170 | Xenon Pharmaceuticals Inc | 626 | 35.1K $ | 0.00 % |
| 171 | Stoke Therapeutics Inc | 1,020 | 33.4K $ | 0.00 % |
| 172 | Trevi Therapeutics Inc | 2,379 | 32.7K $ | 0.00 % |
| 173 | Vaxcyte Inc | 567 | 32.5K $ | 0.00 % |
| 174 | Centene Corp | 597 | 32.1K $ | 0.00 % |
| 175 | Newamsterdam Pharma Co NV | 727 | 20.8K $ | 0.00 % |
| 176 | Nuvalent Inc | 197 | 19.8K $ | 0.00 % |
| 177 | CG oncology Inc | 178 | 11.9K $ | 0.00 % |
| 178 | Alamar Biosciences Inc | 100 | 2.5K $ | 0.00 % |